A prospective study on the effectiveness of metformin and ethinyl estradiol-cyproterone acetate in the management of hyperandrogenism in polycystic ovary syndrome patients
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting 5-8% of women of reproductive age group characterized by associated problems such as infertility, diabetes mellitus, hypertension, dyslipidemia, endometrial cancer, depression and hyperandrogenism. The aim of the review is to evaluate the effectiveness of Metformin and Ethinyl Estradiol- Cyproterone Acetate (EE-CA) in the management of Hyperandrogenism in PCOS patients.